419 related articles for article (PubMed ID: 34735653)
21. How I treat adult T-cell leukemia/lymphoma.
Cook LB; Phillips AA
Blood; 2021 Jan; 137(4):459-470. PubMed ID: 33075812
[TBL] [Abstract][Full Text] [Related]
22. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
23. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
Tsukasaki K; Tobinai K
Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.
Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S
Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of adult T-cell leukemia/lymphoma.
Ishitsuka K
Semin Hematol; 2021 Apr; 58(2):114-122. PubMed ID: 33906721
[TBL] [Abstract][Full Text] [Related]
26. Treatment of adult T-cell leukemia.
Uozumi K
J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
[TBL] [Abstract][Full Text] [Related]
27. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
28. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
Winsett FT; Lewis DJ; Duvic M
Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
[TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
30. Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.
Phillips AA; Harewood JCK
Curr Hematol Malig Rep; 2018 Aug; 13(4):300-307. PubMed ID: 30047026
[TBL] [Abstract][Full Text] [Related]
31. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Ishitsuka K; Tamura K
Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
[TBL] [Abstract][Full Text] [Related]
32. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
33. [Role of anti-CCR4 antibody in the treatment of transplant-eligible patients with aggressive adult T-cell leukemia/lymphoma].
Fuji S
Rinsho Ketsueki; 2018; 59(4):426-431. PubMed ID: 29743403
[TBL] [Abstract][Full Text] [Related]
34. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
35. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H; Ishitsuka K
J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
[TBL] [Abstract][Full Text] [Related]
36. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
37. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.
Kannagi M
Int J Hematol; 2007 Aug; 86(2):113-7. PubMed ID: 17875523
[TBL] [Abstract][Full Text] [Related]
38. Current status of therapeutic approaches to adult T-cell leukemia.
Ishikawa T
Int J Hematol; 2003 Nov; 78(4):304-11. PubMed ID: 14686487
[TBL] [Abstract][Full Text] [Related]
39. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.
Giam CZ; Semmes OJ
Viruses; 2016 Jun; 8(6):. PubMed ID: 27322308
[TBL] [Abstract][Full Text] [Related]
40. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I
Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
